OBINUTUZUMAB for Systemic lupus erythematosus: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 67 adverse event reports in the FDA FAERS database where OBINUTUZUMAB was used for Systemic lupus erythematosus.
Most Reported Side Effects for OBINUTUZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 1,584 | 11.2% | 139 | 239 |
| Neutropenia | 1,276 | 9.0% | 112 | 331 |
| Febrile neutropenia | 955 | 6.7% | 91 | 473 |
| Covid-19 | 942 | 6.6% | 263 | 505 |
| Pyrexia | 920 | 6.5% | 122 | 525 |
| Thrombocytopenia | 889 | 6.3% | 77 | 164 |
| Disease progression | 831 | 5.9% | 184 | 75 |
| Infusion related reaction | 789 | 5.6% | 58 | 252 |
| Pneumonia | 662 | 4.7% | 170 | 445 |
| Anaemia | 640 | 4.5% | 53 | 111 |
| Atrial fibrillation | 548 | 3.9% | 36 | 141 |
| Infection | 517 | 3.6% | 69 | 94 |
| Chills | 483 | 3.4% | 15 | 158 |
| Dyspnoea | 478 | 3.4% | 59 | 187 |
| Nausea | 470 | 3.3% | 37 | 166 |
Other Indications for OBINUTUZUMAB
Chronic lymphocytic leukaemia (4,557)
Follicular lymphoma (2,527)
Product used for unknown indication (1,743)
B-cell lymphoma (1,200)
Diffuse large b-cell lymphoma (1,193)
Mantle cell lymphoma (441)
Non-hodgkin's lymphoma (387)
Lymphoma (238)
Marginal zone lymphoma (188)
Chemotherapy (135)
Other Drugs Used for Systemic lupus erythematosus
BELIMUMAB (15,867)
HYDROXYCHLOROQUINE (5,182)
RITUXIMAB (2,659)
MYCOPHENOLATE MOFETIL (2,645)
PREDNISONE (2,395)
PREDNISOLONE (1,871)
METHOTREXATE (1,440)
AZATHIOPRINE (1,220)
CYCLOPHOSPHAMIDE (1,166)
METHYLPREDNISOLONE (1,135)